Int. J. Mol. Sci. 2013, 14, 23545-23558; doi:10.

3390/ijms141223545
OPEN ACCESS

International Journal of

Molecular Sciences

ISSN 1422-0067
www.mdpi.com/journal/ijms

Article

Pro-Apoptotic Effect of Rice Bran Inositol Hexaphosphate (IP6)

on HT-29 Colorectal Cancer Cells
Nurul Husna Shafie 1, Norhaizan Mohd Esa 1,2,*, Hairuszah Ithnin 3,4, Norazalina Saad 3 and
Ashok Kumar Pandurangan 2
1

Laboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia,

Serdang 43400, Selangor, Malaysia; E-Mail: nhusna.shafie@gmail.com
Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia;
E-Mail: panduashokkumar@gmail.com
UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia,
Serdang 43400, Selangor, Malaysia; E-Mails: hairuszah@upm.edu.my (H.I.);
norazalinasaad@gmail.com (N.S.)
Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia,
Serdang 43400, Selangor, Malaysia

* Author to whom correspondence should be addressed; E-Mail: nhaizan@upm.edu.my;

Tel.: +603-8947-2427; Fax: +603-8942-6769.
Received: 11 October 2013; in revised form: 23 November 2013 / Accepted: 27 November 2013 /
Published: 2 December 2013

Abstract: Inositol hexaphosphate (IP6), or phytic acid is a natural dietary ingredient and
has been described as a natural cancer fighter, being an essential component of
nutritional diets. The marked anti-cancer effect of IP6 has resulted in our quest for an
understanding of its mechanism of action. In particular, our data provided strong evidence
for the induction of apoptotic cell death, which may be attributable to the up-regulation of
Bax and down-regulation of Bcl-xl in favor of apoptosis. In addition, the up-regulation of
caspase-3 and -8 expression and activation of both caspases may also contribute to the
apoptotic cell death of human colorectal adenocarcinoma HT-29 cells when exposed to IP6.
Collectively, this present study has shown that rice bran IP6 induces apoptosis, by
regulating the pro- and anti-apoptotic markers; Bax and Bcl-xl and via the activation of
caspase molecules (caspase-3 and -8).

Int. J. Mol. Sci. 2013, 14

23546

Keywords: inositol hexaphosphate; rice bran; apoptosis; colorectal cancer

1. Introduction
Colorectal cancer (CRC) is the third most common cancer in men and the second most common
cancer in women worldwide [1]. Despite advances in therapeutic interventions over the past decades,
about 40% of the patients will still eventually die because of the disease mainly due to metastasis to
the liver [2]. Cancer generally occurs through a multistep sequence of events where the genomes of
new tumor cells inherit, alter and/or acquire mutant alleles of oncogenes, tumor suppressor genes, and
other genes that control cell proliferation process [3,4] and have abnormal regulation compared to
normal cells. Cells lose their normal features and acquire abnormal characteristics that change the
morphology of cells, protein expression on the surface of the cell membrane, and the regulatory
mechanisms of cell proliferation and death [5].
There is evidence that high consumption of whole grains reduces CRC risk in women [6] and
epidemiological studies, pre-clinical and clinical interventions further support this, highlighting the
possible protective role that minor components of fiber, other nutrients, and phytochemicals present in
wheat bran, grains, and legumes may have against CRC [7]. These include phytic acid or so-called
inositol hexaphosphate (IP6) which is mainly located in the bran fraction of whole-grain cereals,
especially within the aleurone layer. In particular, our study employed rice bran which contains high
concentrations of phytic acid ranging from 5.94 to 6.09 g 100 g1 [8]. IP6 constitutes from 9.5 to
14.5% (w/w) of the rice bran that has been reported to possess various medicinal properties [9].
Promotion of apoptosis is currently a major goal as a strategy for cancer therapy.
Apoptosis-inducing agents may represent a practical mechanistic approach to both cancer
chemoprevention and chemotherapy. Exposure to a hormone or growth factor can easily trigger
apoptosis in normal and malignant cells. Failure of apoptosis through overexpression of cell survival
genes may be involved in the development of many tumors. Additionally, to overcome the initial
problems of existing cancer treatments which that also show adverse effects on normal cells, there is a
need for a more selective therapy that can directly target the apoptosis machinery of cancer cells only,
without affecting normal cells. Many researchers are now focusing on developing novel agents that
may enhance the induction of apoptosis in cancer cells. Agents that selectively target mitochondria,
which is a major target in early apoptosis induction are being investigated in order to develop tumor
selective anti-cancer agents [10]. The Bcl-2 family of proteins in particular, is involved in the control
and regulation of apoptotic mitochondrial events [10,11]. Pro-survival Bcl-2 family members control
the process of apoptosis by regulating pro-apoptotic Bcl-2 family members, such as Bax and Bak [12].
In general, activation of Bax and Bak involves homo-dimerization and oligomerization within the
outer mitochondrial membrane leading to the release of apoptogenic proteins, such as cytochrome c
and Smac/DIABLO, from the mitochondrial inter-membrane space [13]. This in turn, promotes
activation of the caspase signaling cascade that culminates in proteolysis of hundreds of intra-cellular
proteins and consequent cellular destruction. Conversely, both anti-apoptotic proteins, Bcl-2 and
Bcl-xl, inhibit the release of cytochrome c from the mitochondria. Furthermore, Newmeyer et al. [14]

Int. J. Mol. Sci. 2013, 14

23547

reported that the activation of caspase proteases, which are controlled by anti-apoptotic, Bcl-2 and
Bcl-xl lead to the inhibition of apoptotic cell death.
Therefore, agents that can induce apoptosis in cancer cells and spare the normal cells would perhaps
enhance the therapeutic profile in combination with chemotherapy or irradiation; i.e., to reduce adverse
effects due to apoptosis of normal cells [15,16]. IP6 has been shown to inhibit the growth of a wide
variety of tumor cells in multiple experimental model systems. The mechanisms underlying the
apoptosis induction by IP6 seems to be varied and dependent on cell types. Administration with IP6
demonstrated no marked toxicity at the optimal doses required for tumor inhibition [1719].
Furthermore, we found no toxic effects in liver and kidney of rats given IP6 (0.2%0.5% w/v) in
drinking water [20] and likewise no toxicity to the normal 3T3 cell line [21,22].
2. Results
2.1. IP6 Induces Apoptosis and Regulates the mRNA Level of Pro- and Anti-Apoptotic Bax and
Bcl-xl Expression
IP6 treatment showed marked growth inhibition and enhanced apoptotic cell death of human
colorectal adenocarcinoma HT-29 cells in a dose- and time-dependent manner. Initially, we proved
strong evidence that IP6 showed an increase of early apoptosis in HT-29 cells using Annexin V assay.
IP6 elicited its growth inhibitory effects by increasing the total number of apoptosis; 9%, 22% and 41%
following 9.5, 12.0 or 14.5 g/mL of IP6, respectively, relative to the control in a dose-dependent
manner after 24 h of incubation [21]. Moreover, incubation with IP6 (9.5 g/mL) also markedly
increased the total number of apoptoses: 12%, 27% and 38% after 24, 48 or 72 h, respectively, relative
to the control in a time-dependent manner [21]. However, the associated signaling pathways and
cellular events controlling apoptosis were varied depending on the types of cancer and not well
defined. We further examined the molecular mechanism by which IP6 induces apoptotic cell death in
HT-29 cells at mRNA and protein levels.
Apoptosis can be triggered by both internal and external stimuli, causing deregulated mechanisms
in different cancers. Induction of apoptosis is important in cancer treatment. To investigate the
molecular mechanism of apoptosis induced by IP6 in HT-29 cells, the mRNA expression levels of
pro- and anti-apoptotic genes, Bax and Bcl-xl respectively were examined. The melting curve analysis
of the products showed a single peak for each target gene (data not shown). Each gene of interest
resulted in an efficiency of 1.92.1 (slope of 2.9 to 3.5) over a minimum of three-log concentration
range. Furthermore, the similar amplification efficiency of gene of interests with housekeeping genes
was confirmed by assuring a slope of less than 0.1 when CT (the difference between target gene CT
and housekeeping gene CT) was plotted against log concentration of RNA (data was not shown).
Additionally, 5% agarose gel electrophoresis of the PCR product exhibited the presence of a single
product band and the absence of a primer dimer band. The change in mRNA expression was analyzed
using CT method with -actin as housekeeping gene. Figure 1 showed that IP6 treatment of cells at
various doses (9.5, 12.0 or 14.5 g/mL) for 72 h marked a noticeable alteration in Bax and Bcl-xl
mRNA level compared to control (untreated HT-29 cells) (p < 0.05). Notably, IP6 upregulated the
transcript of the pro-apoptotic gene, Bax and downregulated the transcription of the anti-apoptotic

Int. J. Mol. Sci. 2013, 14

23548

gene, Bcl-xl by several fold. The expression level of Bax in HT-29 cells incubated with 9.5, 12.0 or
14.5 g/mL of IP6 for 72 h increased by 3.18, 6.78 or 7.76 fold respectively as compared with control
(Figure 1A). In contrast, the expression level of Bcl-xl in HT-29 cells incubated with 9.5, 12.0 or
14.5 g/mL of IP6 for 72 h reduced by 0.56, 0.34 or 0.18 fold, respectively (Figure 1B). Collectively,
these results show a marked increase in Bax and decrease in Bcl-xl expression that were found to
be dose-dependent.
Figure 1. Expression of apoptotic related genes at mRNA level in HT-29 cells incubated
with IP6. (A) Upregulation of pro-apoptotic, Bax; and (B) Downregulation of anti-apoptotic,
Bcl-xl in a dose-dependent manner. HT-29 cells were incubated with IP6 (9.5; 12 or
14.5 g/mL) for 72 h at 37 C. Results are from 3 independent experiments and presented
as the mean SD. * indicate significant difference by Tukeys test (p < 0.05) relative to
their respective control.

2.2. IP6 Upregulates Caspase Gene Expression

Caspase-8 is an initiator, while caspase-3 is an executioner, where activation of both caspases
represent important biochemical markers that have been identified in cells favoring apoptosis [23].
Figure 2 summarized the gene expression changes of caspase-8 and -3. It was clearly shown that
IP6 upregulated the transcript of caspase-8 and -3 at mRNA level by several folds. The expression
levels of caspase-8 gene in HT-29 cells treated with 9.5, 12.0 or 14.5 g/mL of IP6 for 72 h were
significantly (p < 0.05) increased by 6.38, 10.5 or 11.4 fold, respectively, as compared to the levels in
control (Figure 2A). Similarly, the expression levels of caspase-3 gene in HT-29 cells incubated with
9.5, 12.0 or 14.5 g/mL of IP6 for 72 h increased by 4.63, 5.17 or 11.6 fold, respectively as compared
to the levels in control (Figure 2B). Together, these data suggest that IP6 caused a marked increase in
apoptosis, which was accompanied by upregulation of caspase-8 and caspase-3 expression at mRNA level.

Int. J. Mol. Sci. 2013, 14

23549

Figure 2. Expression of caspases at mRNA level of HT-29 cells incubated with IP6
(A) upregulation of caspase-8 and (B) upregulation of caspase-3 in a dose-dependent
manner. HT-29 cells were incubated with IP6 (9.5, 12.0 or 14.5 g/mL) for 72 h at 37 C.
Results are from 3 independent experiments and presented as the mean SD. * indicate
significant difference by Tukeys test (p < 0.05) relative to their respective control.

2.3. IP6 Modulates Apoptosis Related Protein Expression, Bax and Bcl-xl
In order to establish that the changes in mRNA levels monitored by RT-PCR were reflecting
changes at the protein level and for further confirmation for translation of apoptosis related genes
mRNAs into apoptosis related proteins, western blot analysis was performed in parallel. As mentioned
previously, Bax was upregulated and Bcl-xl was downregulated at the mRNA level after incubation
with IP6 in HT-29 cells as shown in Figure 1. Likely, similar changes can be observed at the protein
level as well. Pro-apoptotic, Bax protein level, which was detected as a 23 kDa band, was significantly
(p < 0.05) increased after IP6 treatment of HT-29 cells in a dose-dependent manner (Figure 3A). The
protein expression level of Bax of HT-29 after incubation with 9.5, 12.0 or 14.5 g/mL for 72 h was
increased by 2.33, 3.65 or 4.3 fold respective to the control. Furthermore, Bcl-xl which was detected as
a 30 kDa band was reduced by 0.21, 0.19 or 0.17 fold after incubation with 9.5, 12.0 or 14.5 g/mL of
IP6, respectively, relative to the control (Figure 3B).

Int. J. Mol. Sci. 2013, 14

23550

Figure 3. The effect of IP6 on apoptotic protein levels in HT-29 cells. (A) IP6 increased
protein expression of Bax; (B) IP6 reduced protein expression of Bcl-xl in a dose-dependent
manner. Results are from 3 independent experiments and presented as the mean SD.
* indicate significant difference by Tukeys test (p < 0.05) relative to their respective control.

2.4. IP6 Activates Caspase-8 and -3

To examine the translational confirmation of caspase-8 and -3, western blot analysis for protein
assay was performed. Interestingly, caspase-8 and -3 protein expression, detected as 55 and 32 kDa
bands respectively, were markedly increased after IP6 treatment of HT-29 cells in a dose-dependent
manner as compared to the control (Figure 4A,B). We clearly observed that both caspases were
significantly (p < 0.05) upregulated by 2.13, 2.7 or 4.37 fold for caspase-8 and 1.24, 1.28 or 2.66 fold
for caspase-3 relative to their respective control following the IP6 treatments (9.5; 12.0 or 14.5 g/mL).
The results showed that the increased caspase-8 was observed in a dose-dependent manner (Figure 4A).
Notably, IP6 has shown significantly (p < 0.05) increased caspase-3 protein expression only after
incubation with the highest dose of IP6, 14.5 g/mL (Figure 4B). The activation of caspase protein
content was due to the proteolytic cleavage of caspases occurred during apoptosis because these
changes were observed after the induction of apoptosis, which in this case triggered after 72 h of IP6
treatment. To further confirm the enzymatic activity of caspase-8 and -3, the colorimetric measurement
of respective substrates of caspases were performed. HT-29 cells were incubated with IP6 for 72 h at
the concentrations of 9.5, 12.0 or 14.5 g/mL. Notably, we observed a significant (p < 0.05) increase in the
activities of both caspase-8 and -3 following the increment of the dose of IP6, demonstrating a
dose-dependent manner (Figure 4C,D). Subsequently, addition of inhibitors of caspase-8 and -3
showed reduced activities were observed. The combination of inhibitor and IP6 showed diminished
activities of caspase-8 and -3. Collectively, these results show an interaction between changes of

Int. J. Mol. Sci. 2013, 14

23551

mRNA and protein levels of caspases after incubation of IP6 in HT-29 cells and activation of caspases
were induced by IP6 as we clearly observed the increment of initiator caspase-8 and executioner caspase-3.
Figure 4. The effect of IP6 on caspase protein levels in HT-29 cells (A) IP6 increased
protein expression of caspase-8 in a dose dependent manner (9.5; 12.0 or 14.5 g/mL of IP6);
(B) IP6 increased the expression of caspase-3 at highest dose of IP6 (14.5 g/mL);
(C and D) The caspase-8 and -3 activities were determined by the incubation with specific
substrates Ac-IETD-pNA (for caspase 8) and Ac-DEVD-pNA (for caspase 3); respectively.
Subsequently addition of inhibitors of caspase 8 (Ac-IETD-CHO) and 3 (Ac-DEVD-CHO)
shows reduction in the activities were observed. The combination of inhibitor and
IP6 showed diminished activities of caspase 8 and 3 were observed. The optical density
was measured at 405 nm as described in materials and methods section. Results are from
3 independent experiments and presented as the mean SD. * and * indicate significant
difference by Tukeys test (p < 0.05) relative to their respective control.

Int. J. Mol. Sci. 2013, 14

23552

3. Discussion
With regards to Bax/Bcl-xl ratio in apoptosis process, Bax supports apoptosis whereas Bcl-xl is an
anti-apoptotic molecule. Therefore, we quantified the expression level of pro-apoptotic and anti-apoptotic
genes before and after incubation with IP6 in HT-29 cells through quantitative RT-PCR and western
blot analysis. Apoptotic induction effect of IP6 on HT-29 cells was observed after 72 h incubation time
whereby Bcl-xl expression was inhibited while Bax expression was markedly increased in a dose
dependent manner. Therefore, it can be implied that apoptosis induced by IP6 may be mediated by the
Bax and Bcl-xl in HT-29 cells.
Furthermore, these data show a correlation of changes in both mRNA and protein levels of Bax,
Bcl-xl, caspase-3 and -8 after incubation with IP6. The downregulation in the expression of Bcl-xl, and
the up-regulation in Bax expression at protein level may cause the collapse of mitochondrial
membrane potential (m), resulting in the release of cytochrome c thus causing apoptosis [24].
Moreover, there is data indicating that overexpression of Bax alone can disrupt mitochondrial
membrane integrity and also that formation of the mitochondrial permeability transition (MPT)
pore [25,26] can occur, resulting in the release of cytochrome c, a situation that favors apoptosis.
It is interesting to note here that Bax has been shown to promote caspase activation by its effects on
mitochondria. This pro-apoptotic Bcl-2 family member induces the release of proteins from the space
between the inner and outer mitochondrial membranes [14]. This process of mitochondrial outer
membrane permeabilization (MOMP) results in the release of cytochrome c and other soluble proteins
into the cytosol. Therefore, additional studies are needed to define whether IP6-mediated alteration in
Bax and Bcl-xl levels activate mitochondrial damage, leading to cytochrome c release and hence
activate caspase in its overall apoptotic response in HT-29 cells.
An increasing number of caspases, also known as cysteine proteases that specifically cleave
proteins after Asp residues, are absolutely required for the accurate and limited proteolytic events that
typify programmed cell death [27]. Thus, it is reasonable to think that caspase activation must play a
role in the apoptotic process in HT-29 cells after incubation with IP6. This was proven by data gathered
from quantitative real-time PCR and western blot analysis, showing that rice bran IP6 promoted the
levels of caspase-3 and -8.
The current data showed a significant increase in the caspase-3 activity in HT-29 cells after IP6
treatment. This agrees with published data by Sharma et al. [28], who found that IP6 has been shown to
significantly increase caspase-3 activity in experimental mouse prostate cancer model. Furthermore,
Schroterova et al., also reported both IP6 and inositol in combination increase the caspase-3 activity on
colorectal carcinoma human cell lines HT-29, SW-480 and SW-620 in a time-dependent manner
enhancing the proapoptotic effect of IP6 [29]. Caspase-3 is activated in the apoptotic cell both by
extrinsic (death ligand) and intrinsic (mitochondrial) pathways [30]. In intrinsic activation, the
up-regulation of Bax by IP6 in HT-29 cells may trigger cytochrome c release from the mitochondria in
combination with caspase-9, apoptosis-activating factor 1 (Apaf-1) and adenosine triphosphate (ATP)
to process procaspase-3 which then activates caspase-3 [31,32]. Therefore, it can be suggested that IP6
induced apoptosis by caspase-3 activation was mediated by Bax.
Natural compounds have the ability to induce apoptosis by modulating the expression of caspase-3 [33].
The activation of caspase-3 induced by IP6 in HT-29 cells also suggested that an alternative pathway of

Int. J. Mol. Sci. 2013, 14

23553

inducing apoptosis might have been activated. The second extrinsic pathway or cell death receptor
pathway is mediated distinctively by active caspase-8 that is characterized by binding cell death ligand
and cell death receptors followed by activation of caspase-8 and caspase-3 [16] for apoptosis to occur.
As mentioned earlier, besides the up-regulation of caspase-3, this present data also showed a
significant increase of caspase-8 after treatment with IP6 in HT-29 cells. This can also suggest that the
increase of caspase-8 led to subsequent activation of downstream caspase-3 (an apoptotic executioner)
which then stimulated the molecular cascade of apoptosis in HT-29 cells.
Moreover, the activated caspase-8 activates caspase-3 through two pathways. In the first pathway,
caspase-8 cleaves BID (Bcl2 Interacting Protein) and its carboxyl (COOH)-terminal part translocates
to mitochondria where it triggers cytochrome c release then activates a caspase signalling cascade
which triggers apoptosis through caspase-3 activation. Another pathway is that caspase-8 cleaves
procaspase-3 directly and activates it [34]. However, further analyses are needed to determine which
pathway triggers caspase-3 activation by IP6. Recently we showed IP6 reduced the tumor number by
modulating the wnt/-catenin pathway during azoxymethane-induced colon cancer in rats [35].
With current data, it can only be suggested that IP6 induced caspase-3 activation may be mediated by
activation of caspase-8. Therefore, taken together, the data presented in this study suggest that IP6-induced
apoptosis are mediated by the death receptor and mitochondrial apoptotic pathways as demonstrated by
increased expression levels of initiator caspase-8 followed by upregulation of caspase-3 and in accordance
with increased and decreased expression level of Bax and Bcl-xl respectively, after IP6 treatment.
4. Experimental Sections
4.1. Chemicals
TRI reagent, 1% agarose gel, tris-borate-EDTA (TBE) buffer and specific primers were purchased
from Sigma (St. Louis, MO, USA). Gene Amp Gold RNA PCR Core Kit was bought from Applied
Biosystems (Foster City, CA, USA). Agarose gel electrophoresis materials were purchased from 1st
Base, Kuala Lumpur, Malaysia. Kapa Sybr Fast qPCR kit (Kapa Biosystems, Boston, MA, USA),
AllPrep DNA/RNA/Protein Mini Kit and QIAshredder homogenizer were bought from Qiagen
(Dusseldorf, Germany). Western blotting reagents were purchased from BioRAD (Hercules, CA, USA).
Dimethylformamide (DMF) was purchased from Fermentas (Vilnius, Lithuania).
4.2. Sample Preparation
Freshly milled raw rice bran samples from mixed local varieties were kindly supplied by the
BERNAS Milling Plant (Selangor, Malaysia). Extraction and isolation of IP6 was initially carried out
according to the established methods in our laboratory [20,36].
4.3. Cell Culture
Cell lines used in this study, HT-29 (human colorectal cancer cell line) was bought from American
Type Culture Collection (ATCC) (Manassas, VA, USA) and the cells were grown in DMEM media
with the following supplements; 10% (v/v) fetal bovine serum (FBS), 100 IU/mL penicillin and

Int. J. Mol. Sci. 2013, 14

23554

100 g/mL streptomycin. Cells were grown in sterile cell culture flask at 37 C in the presence of
5% carbon dioxide (CO2). All steps were performed aseptically in a biosafety hood using sterile equipment.
4.4. Quantification of Apoptosis Related Genes by Real-Time PCR
HT-29 cells were pre-incubated at a density of 1 105 cells in 25 cm2 culture flasks for 24 h. The
culture medium was replaced with fresh aliquots containing IP6 compounds at three different
concentrations based on the IC50 values: (9.5, 12.0 or 14.5 g/mL) that were initially carried out in our
laboratory [21] and incubated for another 72 h. TRI-reagent (Sigma, St. Louis, MO, USA) was used to
extract total RNA directly from cultured cells, according to the manufacturers instructions. Then 1 g
of the total RNA sample was reverse transcribed using the Gene Amp Gold RNA PCR Core Kit
(Applied Biosystem, Foster, CA, USA) in a final reaction volume of 20 L, according to the
manufacturers protocol. The reverse transcription reaction was carried out at 42 C for 30 min in an
authorized thermal cycler (Eppendorf, Hamburg, NY, USA), followed by a 10 min step at 99 C to
denature the enzyme and then it was cooled to 4 C.
The primers used are listed in Table 1, where the nucleotide numbers indicate the primer location in
the corresponding sequences of human origin obtained from National Center for Biotechnology
Information Gene Bank. The specific primers were subsequently validated for the specificity of
amplification, amplification efficiency over a concentration range and consistency with amplification
efficiency of housekeeping gene. All primers used for qRT-PCR were commercially obtained from
Sigma (St. Louis, MO, USA). The mRNA levels of Bax, Bcl-xl, Caspase-8 and Caspase-3 were
assayed using Kapa Sybr Green Fast qPCR kit (Kapa Biosystems, Boston, MA, USA) and was
performed in a reaction volume of 20 L, according to the manufacturers instructions. Real-time PCR
was run according to the following conditions: (i) PCR activation at 95 C for 20 s; (ii) denaturation at
95 C for 3 s and (iii) annealing/extension at 5560 C for 20 s. All samples and controls were run in
triplicate on a Mastercycler realplex system (Eppendorf, Hamburg, NY, USA). The quantitative
RT-PCR data was analyzed using a comparative threshold (CT) method, and the fold inductions of the
samples were compared with the untreated samples. -actin was used as an internal reference gene to
normalize the expression of the target genes.
Table 1. Nucleotide sequence for PCR primers for amplification and sequence-specific
detection of cDNA.
Pair
No

Primer
Name

Accession No

Bax

L22473

Bcl-xL

Z23115

Caspase-3

U26943

Caspase-8

X98172

-actin

X00351

Sequence
Location
nt 172195
nt 516537
nt 381402
nt 903922
nt 340361
nt 720739
nt 10641087
nt 15971621
nt 936955
nt 11701189

Oligonucleotides (5'3')
Sequence
F-AAGCTGAGCGAGTGTCTCAAGCGC
R-TCCCGCCACAAAGATGGTCACG
F-ATGGCAGCAGTAAAGCAAGCGC
R-TTCTCCTGGTGGCAATGGCG
F-TTTGTTTGTGTGCTTCTGAGCC
R-ATTCTGTTGCCACCTTTCGG
F-GGGACAGGAATGGAACACACTTGG
R-TCAGGATGGTGAGAATATCATCGCC
F-CTGTCTGGCGGCACCACCAT
R-GCAACTAAGTCATAGTCCGC

Int. J. Mol. Sci. 2013, 14

23555

4.5. Agarose Gel Electrophoresis

Agarose gel (1% (w/v)) was prepared by adding 0.5 g of agarose to 50 mL of 1 TBE buffer
(121.1 g/L Tris Base, 55.0 g/L Boric acid, 500 mM of EDTA (pH 8)). 10 L of each sample was
mixed with 1.0 L of loading dye [10 mM Tris-HCl (pH 7.6), 0.03% bromophenol blue, 0.03% xylene
cyanol, 60% glycerol, 60 mM EDTA]. 10 L of the appropriate marker was loaded into the first well,
and the electrophoresis unit was run for 1 h at 120 V and 300 mA. The gel was stained in 0.2 g/L of
ethidium bromide solution for 20 min and destained in distilled water for 5 min. The gel was viewed
and photographed under transluminent UV light in a chemiluminescence imager at 302 nm wavelength.
4.6. Western Blot Analysis
Briefly, HT-29 cells were grown in a monolayer in cell culture flasks for 24 h. The culture medium
was replaced with fresh aliquots containing IP6 compounds at three different concentrations; (9.5, 12.0
or 14.5 g/mL) and incubated for another 72 h. After treatment, cells were collected and transferred to
a new RNase-free tube and centrifuged at 1500 rpm for 5 min. Then extraction of total protein from
human cells was performed using AllPrep DNA/RNA/Protein Mini Kit according to the
manufacturers protocols (Qiagen, Duesseldorf, Germany). Protein concentration was determined by
the Bradford assay, according to the manufacturers protocol (BioRAD, Berkeley, CA, USA). The
protein (50 g) was separated by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred onto a piece of PVDF membrane using transfer buffer (25 mM Tris-base,
190 mM glycine, 20% (v/v) methanol; pH 8.3). After transfer, the PVDF membrane was blocked at
room temperature with blocking solution (25 mM Tris-base, 0.3 M NaCl, 5% Milk Diluent) (BioRAD,
Berkeley, CA, USA) for 30 min. After blocking, the membrane was incubated for overnight with
primary antibodies, followed by 2 h with secondary antibodies in Tris-buffered saline (TBS) and
0.5% Tween. Mouse anti-human Bax, Bcl-xl, caspase-8, caspase-3 and -actin antibodies (Santa Cruz
Biotechnology, Dallas, TX, USA) were used at a 1:1000 dilution as the primary antibodies, while
alkaline phosphatase-labeled goat anti-mouse antibody (Santa Cruz Biotechnology, Dallas, TX, USA)
was used at a 1:10,000 dilution as secondary antibody. The membrane was then exposed and protein
bands were detected using developing solution for alkaline phosphatase conjugated antibodies
consisted of 10 mL alkaline phosphatase buffer (100 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl2;
pH 9.5), 33 L BCIP (0.5 g 5-bromo-4-chloro-3-indolylphosphate-p-toluidine salt (Fermentas,
Lithuania, EU) in 10 mL of 100% (v/v) dimethylformamide (DMF)), and 66 L NBT (0.75 g nitroblue
tetrazolium chloride (Fermentas, Lithuania, EU) in 10 mL of 70% (v/v) DMF). The reaction was
stopped when the desired protein band appeared. Densitometric analysis of band intensities obtained
from Western blotting experiments were carried out using ImageJ Software (National Institute of
Health, NIH, Bethesda, MD, USA).
4.7. Measurement of Caspase-3 and 8 Activities
The protease activity of caspases-3 and 8, in HT-29 cells, was assessed using a colorimetric assay
kit (Sigma Aldrich, St. Louis, MO, USA) based on spectrophotometric detection of the caspase
enzymes after cleavage from the labeled substrate. About 3 106 HT-29 cells were treated with IP6 at

Int. J. Mol. Sci. 2013, 14

23556

the concentrations of (9.5, 12.0 or 14.5 g/mL) and incubated for 72 h. Then, the cells were
centrifuged for 5 min at 2000 rpm to remove the media. The cells were then washed two times with
PBS and centrifuged at 2000 rpm for 5 min. The cell pellets were lysed by the addition of 50 L cold
prepared lysis buffer containing 0.5 L DTT and 0.25 L PMSF, mixed well, and incubated on ice for
exactly 1 h. During this time, tubes were vortexed with vibration 34 times for 10 s each time. The
resulting cell lysate was centrifuged for 1 min at 10,000 rpm at 4 C, and the supernatant was collected.
Briefly, the reaction mixture (total volume, 100 L) containing 30 L of cell lysate and 10 L of the
acetyl-Ile-Glu-Thr-Asp-p-nitroaniline (caspase 8 substrate) and acetyl-Asp-Glu-Val-Asp-p-nitroanilide
(caspae 3 substrate) (final concentration, 200 M) in assay buffer, and the assay was carried out in a
96-well plate. The mixtures were incubated for 90 min at 37 C and the absorbance was read at 405 nm
using a Universal Microplate Reader (Bio-TEK. Instrument. Inc., Winooski, VT, USA).
4.8. Statistical Analysis
Data were expressed as the mean standard deviation (SD) and statistically analyzed using SPSS
version 20 (SPSS Inc., Chicago, IL, USA), with a one-way ANOVA with Tukeys test [37,38] and a
significance level of p < 0.05.
5. Conclusions
We clearly showed that rice bran IP6 induces apoptosis, by regulating pro- and anti-apoptotic Bax and
Bcl-xl, as well as through the activation of caspase-3 and -8. These results provide molecular evidence
for how IP6 may elicit the growth inhibition of colon cancer in vitro. Hence, we suggest that inositol
hexaphosphate (IP6), might be useful as a potential preventive and/or therapeutic agent in colon cancer
either alone or as an adjunct to standard chemotherapeutic modalities. Moreover, in the future rice bran
that is normally discarded might increase in value due to its phytonutrient, IP6 potential as
nutraceutical products.
Acknowledgements
We acknowledge the Faculty of Medicine and Health Sciences and Institute of Bioscience, UPM
for their facilities and also appreciate the Ministry of Agriculture (MOA) for Science Fund Project
Grant support.
Conflicts of Interest
The authors declare no conflict of interest.
References
1.
2.
3.

Ferlay, J.; Shin, H.R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. Estimates of worldwide
burden of cancer in 2008: Globocan 2008. Int. J. Cancer 2010, 127, 28932917.
Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012. CA: Cancer J. Clin. 2012, 62, 1029.
Hahn, W.C.; Weinberg, R.A. Mechanisms of disease: Rules for making human tumor cells.
N. Engl. J. Med. 2002, 347, 15931603.

Int. J. Mol. Sci. 2013, 14

4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.

21.

22.

23.
24.

23557

Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646674.
Rieger, P.T. The biology of cancer genetics. Semin. Oncol. Nurs. 2004, 20, 145154.
Larson, S.C.; Giovannucci, E.; Bergkvist, L.; Wolk, A. Whole grain consumption and risk of
colorectal cancer: A population-based cohort of 60,000 women. Br. J. Cancer 2005, 92, 18031807.
Ferguson, L.R.; Harris, P.J. Studies on the role of specific dietary fibres in protection against
colorectal cancer. Mutat. Res. 1996, 350, 173184.
Kasim, A.B.; Edwards, H.M., Jr. The analysis for inositol phosphate forms in feed ingredients.
J. Sci. Food Agric. 1998, 76, 19.
Jariwalla, R.J. Rice bran products: Phytonutrients with potential applications in preventive and
clinical medicine. Drugs Exp. Clin. Res. 2001, 27, 1726.
Adams, J.M.; Cory, S. Bcl-2-regulated apoptosis: Mechanism and therapeutic potential.
Curr. Opin. Immunol. 2007, 19, 488496.
Martinou, J.-C.; Youle, R.J. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial
dynamics. Dev. Cell 2011, 21, 92101.
Youle, R.J.; Strasser, A. The BCL-2 protein family: Opposing activities that mediate cell death.
Nat. Dev. Mol. Cell Biol. 2008, 9, 4759.
Chipuk, J.E.; Green, D.R. How do Bcl-2 proteins induce mitochondrial outer membrane
permeabilization? Trends Cell Biol. 2011, 18, 157164.
Newmeyer, D.D.; Ferguson-Miller, S. Mitochondria: Releasing power for life and unleash in the
machineries of death. Cell 2003, 112, 481490.
Gerl, R.; Vaux, D.L. Apoptosis in the development and treatment of cancer. Carcinogenesis 2005,
26, 263270.
Liu, X.; Yue, P.; Zhou, Z.; Khuri, F.R.; Sun, S.Y. Death receptor regulation and celecoxib-induced
apoptosis in human lung cancer cells. J. Natl. Cancer Inst. 2004, 96, 17691780.
Ullah, A.; Shamsuddin, A.M. Dose-dependent inhibition of intestinal cancer by inositol
hexaphosphate in F344 rats. Carcinogenesis 1990, 11, 22192222.
Vucenik, I.; Sakamoto, K.; Bansal, M.; Shamsuddin, A.M. Inhibition of mammary carcinogenesis
by inositol hexaphosphate (phytic acid). A pilot study. Cancer Lett. 1993, 75, 95102.
Vucenik, I.; Yang, G.Y.; Shamsuddin, A.M. Inositol hexaphosphate and inositol inhibit
DMBA-induced rat mammary cancer. Carcinogenesis 1995, 16, 10551058.
Norazalina, S.; Norhaizan, M.E.; Hairuszah, I.; Norashareena, M.S. Anticarcinogenic efficacy of
phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats.
Exp. Toxicol. Pathol. 2010, 62, 259268.
Nurul-Husna, S.; Norhaizan, M.E.; Hairuszah, I.; Abdah, M.A.; Norazalina, S.; Norsharina, I.
Rice bran phytic acid (IP6) induces growth inhibition, cell cycle arrest and apoptosis on human
colorectal adenocarcinoma cells. J. Med. Plants Res. 2010, 4, 22832289.
Norazalina, S.; Norhaizan, M.E.; Hairuszah, I.; Sabariah, A.R.; Nurul Husna, S.; Norsharina, S.
Antiproliferation and apoptosis induction of phytic acid in hepatocellular carcinoma (HEPG2) cell
lines. Afr. J. Biotechnol. 2011, 10, 1664616653.
Hengartner, M.O. The biochemistry of apoptosis. Nature 2000, 407, 770776.
Bouchier-Hayes, L.; Lartigue, L.; Newmeyer, D.D. Mitochondria: Pharmacological manipulation
of cell death. J. Clin. Invest. 2005, 115, 26402647.

Int. J. Mol. Sci. 2013, 14

23558

25. Bernardi, P.; Krauskopf, A.; Basso, E.; Petronilli, V.; Blachly-Dyson, E.; di Lisa, F.; Forte, M.A.
The mitochondrial permeability transition from in vitro artifact to disease target. FEBS Lett. 2006,
273, 20772099.
26. Bernardi, P.; von Stockum, S. The permeability transition pore as a Ca(2+) release channel:
New answers to an old question. Cell Calcium 2012, 52, 2227.
27. Degterev, A.; Boyce, M.; Yuan, J. A decade of caspases. Oncogene 2003, 22, 85438567.
28. Sharma, G.; Singh, R.P.; Agarwal, R. Growth inhibitory and apoptotic effects of inositol
hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells. Int. J. Oncol.
2003, 23, 14131418.
29. Schroterova, L.; Haskova, P.; Rudolf, E.; Cervinka, M. Effect of phytic acid and inositol on the
proliferation and apoptosis of cells derived from colorectal carcinoma. Oncol. Rep. 2010, 23,
787793.
30. Salvesen, G.S. Caspases: Opening the boxes and interpreting the arrows. Cell Death Differ. 2002,
9, 35.
31. Li, P.; Nijhawan, D.; Wang, X. Mitochondrial activation of apoptosis. Cell 2004, 116, 5759.
32. Katunuma, N.; Matsui, A.; Le, Q.T.; Utsumi, K.; Salvesen, G.; Ohashi, A. Novel procaspase-3
activating cascade mediated by lysoapoptases and its biological significances in apoptosis.
Adv. Enzyme Regul. 2001, 41, 237250.
33. Pandurangan, A.K.; Dharmalingam, P.; Ananda Sadagopan, S.K.; Ramar, M.; Munusamy, A.;
Ganapasam, S. Luteolin induces growth arrest in colon cancer cells through involvement of
Wnt/-catenin/GSK-3. J. Environ. Pathol. Toxicol. Oncol. 2013, 32, 131139.
34. Czerski, L.; Nuez, G. Apoptosome formation and Caspase activation: Is it different in the heart?
J. Mol. Cell. Cardiol. 2004, 37, 643652.
35. Shafie, N.H.; Mohd Esa, N.; Ithnin, H.; Md Akim, A.; Saad, N.; Pandurangan, A.K.
Preventive Inositol Hexaphosphate (IP6) extracted from rice bran inhibits colorectal cancer
through involvement of Wnt/-catenin and COX-2 pathways. BioMed Res. Int. 2013, 2013, 110.
36. Saad, N.; Esa, N.M.; Ithnin, H.; Shafie, N.H. Optimization of optimum condition for phytic acid
extraction from rice bran. Afr. J. Plant Sci. 2011, 5, 168175.
37. Pandurangan, A.K.; Dharmalngam, P.; Anandasadagopan, S.K.; Ganapasam, S. Effect of luteolin
on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice.
Asian Pac. J. Cancer Prev. 2012, 13, 15691573.
38. Karthikeyan, K.; Bai B.R.; Devaraj, S.N. Cardioprotective effect of grape seed proanthocyanidins
on isoproterenol-induced myocardial injury in rats. Int. J. Cardiol. 2007, 115, 326333.
2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/3.0/).